KINETIC-PROPERTIES OF BILIRUBIN UDP-GLUCURONYLTRANSFERASE IN SQUIRREL-MONKEYS EXHIBITING FASTING HYPERBILIRUBINEMIA

被引:6
作者
FREEDLAND, RA
SMITH, CA
BRUSS, ML
CORNELIUS, CE
机构
[1] UNIV CALIF DAVIS,SCH VET MED,DEPT PHYSIOL SCI,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,CALIF PRIMATE RES CTR,DAVIS,CA 95616
来源
INTERNATIONAL JOURNAL OF BIOCHEMISTRY | 1991年 / 23卷 / 09期
关键词
D O I
10.1016/0020-711X(91)90073-V
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1. Bolivian squirrel monkeys (BoSM), unlike Brazilian squirrel monkeys (BrSM), exhibit a marked fasting hyperbilirubinemia (FH) and serve as animal models for Gilbert's syndrome type 1. 2. Compared to BrSM, BoSM possess a higher apparent (UDPGA)K(m) (0.51 vs 0.29 mM) and lower V(m) (0.36 vs 0.48 nmol BR conjugated/min per mg microsomal protein) for hepatic bilirubin (BR) UDP-glucuronyltransferase (BR UDPG-T). 3. Lineweaver-Burk plots are linear and obey Michaelis-Menten kinetics when UDP-acetylglucosamine is used as activator and UDPGA substrate concentrations are within the physiologic range present in the liver during the fed and fasted state (0.10-0.71 mM); above these concentrations, there is a discontinuity of kinetic plots as noted in other species. 4. There is no effect of fasting on the K(m) of BR conjugation (i.e. sum of mono- and diglucuronides) in either monkey; however, fasting is associated with lower V(m) values (15-20%) in each subspecies. 5. By calculating the potential BR flux (nmol BR conjugated/min per kg) using known hepatic UDPGA concentrations, liver weights and in vitro K(m) and V(m), a markedly lower BR flux is observed in BoSM (58.4 nmol/min per kg) than in BrSM (91.6 nmol/min per kg). 6. Significantly higher apparent (UDPGA)K(m) and lower V(m) of BR UDPG-T for conjugation of BR to BR monoglucuronide appears responsible in part for the four- to five-fold elevations in unconjugated BR in the liver and plasma in the fasted BoSM.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 43 条
[1]   CHRONIC NONHEMOLYTIC UNCONJUGATED HYPERBILIRUBINEMIA WITH GLUCURONYL TRANSFERASE DEFICIENCY - CLINICAL, BIOCHEMICAL, PHARMACOLOGIC AND GENETIC EVIDENCE FOR HETEROGENEITY [J].
ARIAS, IM ;
GARTNER, LM ;
COHEN, M ;
EZZER, JB ;
LEVI, AJ .
AMERICAN JOURNAL OF MEDICINE, 1969, 47 (03) :395-&
[2]  
ARIGA S, 1978, J MED PRIMATOL, V7, P129
[3]  
Berk PB, 1986, BILE PIGMENTS JAUNDI, P279
[4]  
Berk PD, 1980, METABOLIC CONTROL DI, P1009
[5]  
BERK PD, 1974, EPATOLOGIA, V20, P245
[6]  
BERRY CS, 1978, LIVER QUANTITATIVE A, P226
[7]  
BILLINGS BH, 1981, FAMILIAL HYPERBILIRU, P1
[8]   HEPATIC BILIRUBIN UDP-GLUCURONYL TRANSFERASE ACTIVITY IN LIVER DISEASE AND GILBERTS SYNDROME [J].
BLACK, M ;
BILLING, BH .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (23) :1266-&
[9]  
BLANCKAERT N, 1980, BIOCHEM J, V185, P198
[10]  
BLANCKAERT N, 1977, BIOCHEM J, V167, P535